Author(s): Walter Fiedler, Joerg Chromik, Stefanie Amberg, et. al.: EHA Library. Fiedler W. Jun 15, 2019; 267463; S880 Abstract: S880 Session topic: 4. Acute myeloid leukemia – Clinical Background Patients with relapsed/refractory (R/R) AML have a dismal prognosis. Currently, no salvage chemotherapy regimen has gained universal acceptance. Selinexor, an oral inhibitor of...
Pro zobrazení tohoto obsahu je třeba být přihlášen.